Latest News from Euretina 2022

Delegates attending Saturday afternoon’s Speakers’ Corner session on imaging heard colleagues describe interesting cases and findings from prospective and retrospective clinical studies evaluating the performance of different imaging platforms for characterising known and recently described retinal features associated with common and rare diseases.   Speakers’ Corner, a popular feature of...

A study detailing the pros and cons of using silicone oil as a long-term tamponade agent after complex retinal surgery was the winner of the inaugural August Deutman prize for the best e-Poster. “We know that silicone oil is a widely used tamponade agent in complex retinal surgery, but it...

Delegates filling the Auditorium on Saturday morning for the RETINAWS video course were rewarded with a valuable learning experience as top surgeons from around the world presented and discussed video excerpts showcasing complex vitreoretinal surgery, rare situations, and unique surgical techniques. The session started, however, with course director Dr Kourous...

The PULSAR trial in wet age-related macular degeneration demonstrated that aflibercept 8 mg administered every 12 or 16 weeks is noninferior in vision gains compared with aflibercept 2 mg every 8 weeks. The 60-week and 96-week outcomes of the trial were presented by Paolo Lanzetta MD, who was designated winner...

Everybody loves a good detective mystery and retinal specialists are no exception.  At the Medical Retina Mystery Cases session, the assembled audience was presented with a wide variety of puzzling case studies which highlighted the complex process of arriving at a correct diagnosis. Opening the session, Srinivas Sadda MD presented...

If current trends continue, one out of every two people on the planet will be myopic by the year 2050. Even more worryingly, a significant proportion of these will be highly myopic with all the associated problems that entails in terms of ocular morbidity, disease and vision loss, according to...

Prof. Ramin Tadayoni, the incoming President of EURETINA, discusses the challenges and opportunities facing the Society over the next few years To what do you attribute the phenomenal growth of EURETINA in recent years? Ramin Tadayoni: EURETINA is still quite a young Society and a lot has been achieved in...

Speakers at the Euretina session on imaging reviewed applications for a variety of retinal diseases. Leading off the programme, Dr Pearse Keane (UK) discussed the application of artificial intelligence (AI) for analysing OCT scans and predicted that the biggest impact of the application of AI in AMD in the near...

Presentations by Ukrainian retina specialists speaking at the Ukraine Support Symposium on Friday afternoon described the devastating eye injuries suffered by Ukrainian soldiers and civilians in the ongoing war with Russia and described the complex surgical approaches needed to manage these traumatic cases.   Opening the session, Dr Camiel Boon...

There are 8,000 registered attendees for the 23rd Euretina Congress in Amsterdam, also marking a return to the level of in-person attendance last seen in 2019.  At the beginning of the opening ceremony on Thursday afternoon, Euretina President Dr Alistair Laidlaw extended a very warm welcome to those who gathered...

A huge number of Euretina Congress delegates filled the Grand Auditorium to hear speakers at the first Euretina Session of the meeting. The session focused on vitreoretinal surgery and specifically centred on evidence-based medicine approaches in cases of retinal detachment and macular holes.   The primary aim of the session...

‘Debate Corner’ was introduced as a new feature of the Euretina Congress at the 2023 meeting. Based on the large standing room only crowd in attendance at the first of these sessions held in a corner of the Exhibit Hall, the format is a huge success. The purpose of the...

Mix of formats engage attendees and enhance learning in the 136th Retinal Detachment Teaching Course EURETINA delegates who attended the Retinal Detachment Teaching Course represent participants in the 136th iteration of this programme that was first organised by Professor Ingrid Kreissig in 1991. The course at the EURETINA Congress is...

Retina specialists who have innovative ideas for new therapies and devices heard encouraging words from panellists participating in the “Investing in Retina” session at the EURETINA Innovation Spotlight. Representing European- and US-based venture capital firms that provide financing for research and development of entities that may be just a new...

Evidence of burgeoning research to develop new medical therapeutics for retinal diseases was strong at the EURETINA Innovation Spotlight (EIS) where two 75-minute sessions were devoted to innovation in medical therapy. During the dual sessions, speakers representing 13 companies took to the podium to showcase their company’s pipeline, and panel...

The Inaugural EURETINA Innovation Spotlight (EIS) held on October 4th, 2023 brought together the stakeholders involved in the development of the next generation innovative retinal therapies and diagnostics. In launching this new event, the goal of EURETINA was to create and foster communication and collaboration to advance and improve the...

Survey participants will be entered into a raffle to receive a free Delegate registration for the EURETINA 2024 Congress in Barcelona and will receive a summary report before it is published. The sixth annual EURETINA Clinical Trends Survey is underway here in Amsterdam at the 2023 meeting. This survey builds...

Gisbert Richard lecturer describes her 20+ year collaboration with engineering, computer science, and clinical colleagues and their ongoing journey to improve eye care through innovations in handheld and intraoperative OCT Without exclusion, retina specialists recognise the value brought by optical coherence tomography (OCT) to the care of patients with retinal...

In his initial message inviting colleagues to the 23rd Euretina Congress in Amsterdam, Euretina President Alistair Laidlaw said, “Sustainability will once again be at the core of our conference organisation as we continue to measure and lower our carbon output.” “Euretina is committed to improving the sustainability of our Congress,...

In the 2023 Kreissig Lecture, Professor Shwu-Jiuan Sheu MD, will outline the potential advantages and pitfalls of employing vitreretinal surgery as a management strategy for uveitis. In this interview, she discusses the key points she will raise in her lecture. What is driving the development of VR surgery as a...

A group of 69 applicants seeking to become the first recipients of the FEBOS-R completed the examination process on Wednesday 4th of October, the day before the start of the Euretina Congress. While registration for next year’s exams will not open until November, physicians interested in pursuing the FEBOS-R diploma...

Ophthalmologica Award lecturer reviews the challenges faced in demonstrating the efficacy of investigational treatments for atrophic retinal diseases and possible solutions Geographic atrophy (GA) secondary to age-related macular degeneration (AMD), and Stargardt disease (STGD) are leading causes of blindness in the elderly and working-age populations, respectively. While no therapy for...

EURETINA Lecture to highlight the unique knowledge and skills carried by oncoVR surgeons and their contributions for improving the care of patients with intraocular tumours Vitreoretinal surgery has an essential role in the diagnosis and management of intraocular tumours. In his EURETINA Lecture entitled “OncoVR – A new subspecialty”, Dr...